-
research programme, the first of its kind in the world, supported by Inkfish with £35M core funds over six years, starting in April 2025. It is a global study of 60,000 participants, including 20,000 mothers
-
of the UK-Irish Atopic Eczema Systemic TherApy Register (A-STAR). A-STAR is the UK’s flagship register of atopic eczema patients on systemic therapies, under the leadership of Professor Carsten Flohr, Chair
-
place. We are delighted to announce exciting new opportunities to join our community. EMBRACE is a visionary, multicomponent international research programme, the first of its kind in the world
-
details:Sam Norton (Professor of Medical Statistics & Applied Health Research). sam.norton@kcl.ac.uk Location: Guy's Campus & Denmark Hill Campus. Category: Research. About us: King’s College London is one